FDA Approves Steglatro (ertugliflozin) for Type 2 Diabetes

KENILWORTH, N.J. & NEW YORK–(BUSINESS WIRE) December 22, 2017 — Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Pfizer Inc. (NYSE:PFE), today announced that the U.S. Food and Drug Administration (FDA) has approved…

Pharmaceutical Stocks

[stock-ticker]

© 2018 Drugs News All rights reserved.       Privacy Policy       Contact Us